DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$12.34
0.10 (0.82%)
▲
5d:
+3.44%
30d:
+13.94%
90d:
+34.13%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 0% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $12.34, which is considered extended relative to its 30-day fair value range of $10.73 to $11.84. From a valuation perspective, the stock is trading at a discount (Forward PE: -24.0) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.35 (+74.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.35 (+74.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.73 -
$11.84
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 74.4% below Wall St target ($21.35)
Trading Range Analysis
30-Day Trading Range
$10.73 -
$11.84
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.03
(8.4%)
Support & Resistance Levels
Support Level
$10.20
Resistance Level
$12.17
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-24.00
Wall Street Target
$21.35
(+74.4%)
Revenue Growth (YoY)
26.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
0.6%
PE vs Historical
-24.0 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: June 25, 2026 1:40 PM ET
Data refreshes hourly during market hours. Next update: 2:40 PM
Data refreshes hourly during market hours. Next update: 2:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
